PDF(543 KB)
Real-world study of the efficacy， safety and economic comparison of vedolizumab versus infliximab in treating moderate-to-severe ulcerative colitis in primary care hospitals
CHEN Wei, LIANG Shihui, CHEN Ruiyun, WU Dong, YANG Zhenfeng, WANG Qi, WANG Yanyan, LI Guangli
Chinese Journal of Hospital Pharmacy ›› 2025, Vol. 45 ›› Issue (14) : 1659-1664.
PDF(543 KB)
PDF(543 KB)
Real-world study of the efficacy， safety and economic comparison of vedolizumab versus infliximab in treating moderate-to-severe ulcerative colitis in primary care hospitals
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
